Mosaic ImmunoEngineering Inc. (CPMV) stock
CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.33+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Mosaic ImmunoEngineering free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Mosaic ImmunoEngineering's free cash flow for the twelve months ending May 31, 2019 was -$760.77K. For fiscal 2019 it was -$760.77K. The highest annual figure on record is -$760.77K in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | May 31, 2019 | -$760.77K | – |
| FY2018 | May 31, 2018 | -$881.64K | – |
| FY2017 | May 31, 2017 | -$1.31M | – |
| FY2016 | May 31, 2016 | -$1.58M | – |
| FY2015 | May 31, 2015 | -$1.35M | – |
| FY2014 | May 31, 2014 | -$1.50M | – |
| FY2013 | May 31, 2013 | -$1.01M | – |
| FY2012 | May 31, 2012 | -$2.40M | – |
| FY2011 | May 31, 2011 | -$4.33M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$229.12K | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$209.35K | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$187.89K | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$255.47K | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$228.92K | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$386.07K | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$230.99K | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | -$274.59K | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | -$421.90K | – |
| Q4 FY2016CQ2 2016 | May 31, 2016 | -$360.08K | – |
| Q3 FY2016CQ1 2016 | Feb 29, 2016 | -$358.97K | – |
| Q2 FY2016CQ4 2015 | Nov 30, 2015 | -$307.81K | – |
| Q1 FY2016CQ3 2015 | Aug 31, 2015 | -$551.42K | – |
| Q4 FY2015CQ2 2015 | May 31, 2015 | -$333.08K | – |
| Q3 FY2015CQ1 2015 | Feb 28, 2015 | -$212.55K | – |
See a number that looks wrong?